CLOS
CYTK icon

Compagnie Lombard Odier SCmA’s Cytokinetics CYTK Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,000
Closed -$243K – 742
2016
Q4 		$243K Hold
20,000
– – 0.01% 422
2016
Q3 		$184K Buy
+20,000
New +$209K 0.01% 483

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Compagnie Lombard Odier SCmA's CYTK Position: Q1 2017 in Review

Compagnie Lombard Odier SCmA sold out of Cytokinetics (CYTK) in Q1 2017, closing a stake of 20,000 shares — an estimated $243K sold.

Compagnie Lombard Odier SCmA first reported a position in CYTK in Q3 2016 and held it in 2 quarters. The position peaked at $243K in Q4 2016. 108 funds tracked by Wall St. Rank hold CYTK as of Q1 2017.

  • Compagnie Lombard Odier SCmA reported no remaining Cytokinetics position as of Q1 2017 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 20,000 Cytokinetics shares in Q1 2017, an estimated $243K.
  • Compagnie Lombard Odier SCmA first reported a position in Cytokinetics in Q3 2016 and held it in 2 quarters.
  • Compagnie Lombard Odier SCmA's Cytokinetics position peaked at $243K in Q4 2016.
  • 108 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2017, filed 15 May 2017.